Introduction: Clinical staging of localized renal masses is assigned according to radiographic tumor diameter cut-offs, with T1 masses defined as 7cm or less compared to T2 masses. However, it is unknown if tumors with infinitesimal size differences exhibit oncologic behavior to warrant different surgical management. Arbitrarily dichotomizing otherwise similar tumors to different stage groups may inappropriately influence the management of renal tumors, which may affect patient outcomes. We evaluated differences in management and clinical outcomes in otherwise similarly sized tumors among patients that differ only in clinical T stage.
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